Latent transforming growth factor-β binding protein-1, a component of latent transforming growth factor-β complex, accelerates the migration of aortic smooth muscle cells in diabetic rats through integrin-β3

Diabetes

Volumn 52, Issue 3, 2003, Pages 824-828

  Kanzaki, Tetsuto ^a   Otabe, Masako ^a  

^a 1 7 1 Kohnodai   (Japan)

Author keywords

8 Cys, 8 cysteine; BCI, balloon catheter inqury; DMEM, Dulbecco's modified Eagles medium; EGF, epidermal growth factor; FBS, fetal bovine serum; LAP, latency associated peptide; LTBP, latent TGF 1 binding protein

Indexed keywords

BETA3 INTEGRIN; FIBRONECTIN; LATENCY ASSOCIATED PEPTIDE; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CROSS LINKING; DIABETES MELLITUS; DIABETIC ANGIOPATHY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR WEIGHT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STREPTOZOCIN DIABETES; THICKNESS;

ANIMALS; ANTIBODIES, MONOCLONAL; AORTA; CARRIER PROTEINS; CELL DIVISION; CELL MOVEMENT; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR;

EID: 0037342157     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.3.824     Document Type: Article

References (48)

1. Kanzaki T, Shiina R, Saito Y, Zardi L, Morisaki N: Transforming growth factor-β receptor and fibronectin expressions in aortic smooth muscle cells in diabetic rats. Diabetologia 40:383-391, 1997
2. Kawano M, Koshikawa T, Kanzaki T, Morisaki N, Saito Y, Yoshida S: Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF β-receptors. Eur J Clin Invest 23:84-90, 1993
3. Tamura K, Kanzaki T, Tashiro J, Yokote K, Mori S, Ueda S, Saito Y, Morisaki N: Increased atherogenesis in Otsuka Long-Evans Tokushima fatty rats before the onset of diabetes mellitus: association with overexpression of PDGF β-receptor in aortic smooth muscle cells. Atherosclerosis. 149:351-358, 2000
4. Kanzaki T, Shinomiya M, Ueda S, Morisaki N, Saito Y, Yoshida: Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF β-receptor overexpression of aortic media. Eur J Clin Invest 24:377-381, 1994
5. Hedin U, Thyberg J: Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 33:239-246, 1987
6. Roberts AB, Sporn MB: The transforming growth factor-βs. In Peptide Growth Factors and Their Receptors. Part I. Sporn MB, Roberts AB, Eds. Berlin, Springer-Verlag, 1990, p. 419-472
7. Pircher R, Lawrence DA, Jullien P: Latent β-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res 44:5538-5543, 1984
8. Pircher R, Jullien P, Lawrence DA: β-transforming growth factor is stored in human platelets as a latent high molecular weight complex. Biochem Biophys Res Commun 136:30-37, 1986
9. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueda M, Morisaki N: In vivo effect of TGF-β1: enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 15:1951-1957, 1995
10. Nabel EG, Shum L, Pompili VJ, Yang Z-Y, San H, Shu HB, Libtay S, Gold L, Gordon D, Derynck R, Nabel GJ: Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A 90:10759-10763, 1993
11. Bottinger EP, Factor VM, Tsang ML-S, Weartherbee J, Kopp J, Qian S, Wakefield L, Roberts A, Thorgeirsson S, Sporn M: The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc Natl Acad Sci U S A 93:5877-5882, 1996
12. Stenman G, Sahlin P, Olofsson A, Geurts van Kessel A, Miyazono K: Assignment of the gene encoding the latent TGF-β-1-binding protein (LTBP1) to human chromosome 2, region p12-q22. Cytogenet Cell Genet 66:117-119, 1994
13. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin C-H: TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051-1061, 1990
14. Tsuji T, Okada F, Yamaguchi K, Nakamura T: Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci U S A 87:8835-8839, 1990
15. Moren A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, ten Dijke P, Miyazono K, Heldin C-H: Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem 269:32469-32478, 1994
16. Yin W, Smiley E, Germiller J, Mecham RP, Florer JB, Wenstrup RJ, Bonadio J: Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J Biol Chem 270:10147-10160, 1995
17. Giltay R, Kostka G, Timpl R: Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-β binding proteins. FEBS Lett 411:164-168, 1997
18. Maslen CL, Corson GM, Maddox BK, Glanville RW, Sakai LY: Partial sequence of a candidate gene for the Marfan syndrome. Nature 352:334-337, 1991
19. Zhang H, Apfelroth SD, Hu W, Davis EC, Sanguineti C, Bonadio J, Mecham RP, Ramirez F: Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 124:855-863, 1994
20. Mangasser-Stephan K, Gressner AM: Molecular and functional aspects of latent transforming growth factor-β binding protein: just a masking protein? Cell Tissue Res 297:363-370, 1999
21. Miyazono K, Olofsson A, Colosetti P, Heldin C-H: A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta1. EMBO J 10:1091-1101, 1991
22. Olofsson A, Ichijo H, Moren A, ten Dijike P, Miyazono K, Heldin C-H: Efficient association of an amino-terminally extended form in human latent transforming growth factor-beta binding protein with the extracellular matrix. J Biol Chem 270:31294-31297, 1995
23. Unsold C, Hyytiainen M, Bruckner-Tuderman L, Keski-Oja J: Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 114:187-197, 2001
24. Dalles SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF: Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as structural matrix protein. J Cell Biol 131:539-549, 1995
25. Nakajima Y, Miyazono K, Kato M, Takase M, Yamagishi T, Nakamura H: Extracellular fibrillar structure of latent TGF-β binding protein-1: role in TGF-β-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J Cell Biol 136:193-204, 1997
26. Kanzaki T, Shiina R, Saito Y, Oohashi H, Morisaki N: Role of TGF-β1 binding protein in vascular remodeling. Biochem Biophys Res Commun 246:26-30, 1998
27. Waltenberger J, Akyurek ML, Aurivillius M, Wanders A, Larsson E, Fellstrom B, Funa K: Ischemia-induced transplant arteriosclerosis in the rat: induction of peptide growth factor expression. Arterioscler Thromb Vasc Biol 16:1516-1523, 1996
28. Taipale J, Saharinen J, Hedman K, Keski-Oja J: Latent transforming growth factor beta-1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44:875-889, 1996
29. Fisher-Dzoga K, Jones RM, Vesselinovitch D, Wissler RW: Ultrastructural and immunohistochemical studies of primary cultures of aortic medial cells. Exp Mol Pathol 18:162-176, 1973
30. Ooyama T, Fukuda K, Oda H, Nakamura H, Hikita Y: Substratum-bound elastin peptide inhibits aortic smooth muscle cell migration in vitro. Arteriosclerosis 7:593-598, 1987
31. Frolik CA, Wakefield LM, Smith DM, Sporn MB: Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J Biol Chem 259:10995-11000, 1984
32. Ichijo H, Momose F, Miyazono K: Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cells. Exp Cell Res 187:263-269, 1990
33. 1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration. Circulation 97:1818-1827, 1998
34. Mitchison TJ, Cramer L: Actin-based cell motility and cell locomotion. Cell 84:371-379, 1996
35. 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713-724, 1995
36. Matsuno H, Stassen JM, Vermylen J, Deckmyn H: Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 90:2203-2206, 1994
37. 3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 94:9308-9313, 1997
38. 3 and osteopontin expression during neointima formation. Cardiovasc Res 36:408-428, 1997
39. 3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits. Circ Res 84:1268-1276, 1999
40. 3 integrin. Arterioscler Thromb Vasc Biol 20:1467-1472, 2000
41. 3 integrin expression in normal and atherosclerotic artery. Circ Res 77:1129-1135, 1995
42. 3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 97:907-915, 1998
43. 1 and by plateletderived growth factor-BB. J Cell Physiol 151:588-595, 1992
44. Basson CT, Kocher O, Basson MD, Asis A, Madri JA: Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β1 correlates with reciprocal effects on cell migration. J Cell Physiol 153:118-128, 1992
45. 5 mediate VSMC migration and are elevated during neointima formation in the rat aorta. Basic Res Cardiol 96:42-49, 2001
46. 3 is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor. J Cell Biochem 83:129-135, 2001
47. 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg 19:125-134, 1994
48. Ross R: The pathogenesis of atherosclerosis-an update. N Engl J Med 314:488-500, 1986